BioWorld

June 4, 2010

View Archived Issues

Molecular Reasons Behind Tamiflu Resistance Found

Read More

RetroVirox Building Antiviral Candidates for Others to Grow

Read More

Clinic Roundup

Read More

Stock Movers

Read More

Other News To Note

Read More

Arena Raising $35.5M in Stock Sale to Deerfield as PDUFA Date Looms

Arena Pharmaceuticals Inc. has agreed to sell shares to Deerfield Management for $35.5 million, money that will bolster the biotech's cash as it seeks FDA approval of its obesity compound lorcaserin. (BioWorld Today) Read More

Tioga Seeking to Change D-IBS Landscape with PIII Under Way

Read More